632 related articles for article (PubMed ID: 24856528)
1. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
Somoskovi A; Salfinger M
Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528
[TBL] [Abstract][Full Text] [Related]
2. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
Camarena Miñana JJ; Pellicer RG
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
Andréjak C; Lescure FX; Schmit JL; Jounieaux V
Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
[TBL] [Abstract][Full Text] [Related]
4. Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy.
Porvaznik I; Solovič I; Mokrý J
Adv Exp Med Biol; 2017; 944():19-25. PubMed ID: 27826888
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a membrane array for detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in positive liquid cultures.
Lu PL; Lin YC; Yang YC; Jou R; Huang SC; Jenh YS; Huang HH; Chang TC
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):337-41. PubMed ID: 23514755
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.
Brown-Elliott BA; Woods GL
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31315954
[TBL] [Abstract][Full Text] [Related]
7. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Non-tuberculous Mycobacterial Infections in Category II Failures from National Tuberculosis Programme.
Dholakia YN; Shah DP
Indian J Chest Dis Allied Sci; 2015; 57(1):27-30. PubMed ID: 26410980
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.
Hwang SM; Lim MS; Hong YJ; Kim TS; Park KU; Song J; Lee JH; Kim EC
Tuberculosis (Edinb); 2013 Nov; 93(6):642-6. PubMed ID: 23988279
[TBL] [Abstract][Full Text] [Related]
10. Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions
Lin C; Russell C; Soll B; Chow D; Bamrah S; Brostrom R; Kim W; Scott J; Bankowski MJ
Emerg Infect Dis; 2018 Mar; 24(3):485-491. PubMed ID: 29460734
[TBL] [Abstract][Full Text] [Related]
11. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
12. Paradigm for diagnosing mycobacterial disease: direct detection and differentiation of
Kim JU; Ryu DS; Cha CH; Park SH
J Clin Pathol; 2018 Sep; 71(9):774-780. PubMed ID: 29559518
[TBL] [Abstract][Full Text] [Related]
13. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
14. Non-tuberculous mycobacteria profiles and their anti-mycobacterial resistance at a major medical center in Lebanon.
Araj GF; Baba OZ; Itani LY; Avedissian AZ; Sobh GM
J Infect Dev Ctries; 2019 Jul; 13(7):612-618. PubMed ID: 32065818
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
16. Laboratory aspects of clinically significant rapidly growing mycobacteria.
Set R; Shastri J
Indian J Med Microbiol; 2011; 29(4):343-52. PubMed ID: 22120792
[TBL] [Abstract][Full Text] [Related]
17. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
[TBL] [Abstract][Full Text] [Related]
18. Identification and drug susceptibility testing for nontuberculous mycobacteria.
Huang WC; Yu MC; Huang YW
J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S32-S41. PubMed ID: 32423573
[TBL] [Abstract][Full Text] [Related]
19. Culture, Identification, and Antimicrobial Susceptibility Testing of Pulmonary Nontuberculous Mycobacteria.
Khare R; Brown-Elliott BA
Clin Chest Med; 2023 Dec; 44(4):743-755. PubMed ID: 37890913
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
